ReviewJournal of oral & facial pain and headache2026
Beyond the jaw: vocal, oropharyngeal and cognitive-linguistic biomarkers for precision pain phenotyping in TMD.
Review in Journal of oral & facial pain and headache, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Temporomandibular disorders (TMDs) represent a group of conditions affecting the temporomandibular joint and its associated musculature. TMD is the leading cause of chronic orofacial pain. Current assessment relies heavily on patient-reported outcomes, which capture pain intensity and its impact but provide limited mechanistic or functional insight. This narrative conceptual review proposes a framework for investigating vocal, oropharyngeal, and cognitive-linguistic (VOCL) features as candidate behavioral biomarkers for precision pain phenotyping in TMD. We synthesize the literature from TMD and related neurological and chronic pain conditions to examine how alterations in neuromuscular control, autonomic regulation, and cognitive burden could plausibly manifest as changes in acoustic voice metrics, motor speech performance, swallowing function, and cognitive-linguistic tasks. Given the limited TMD-specific empirical evidence available to date, we outline a staged validation roadmap that specifies TMD subgroups, study designs, confounder control strategies, and reliability considerations necessary before clinical application. While promising, VOCL features should be regarded as investigational constructs requiring rigorous validation. Establishing standardized protocols and integrating VOCL measures with psychological and physiological domains may clarify the potential role of VOCL in TMD phenotyping and monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.